Examiner Brown-Pettigrew Angela C (SPE)

1761-BROWN-PETTIGREW-ANGELA-C

Employment Information

Art Unit:1761 — Cleaning compositions for solid surfaces, auxiliary compositions therefor, or processes of preparing the compositions
Group:1760 — Organic Chemistry, Polymers, Compositions
Classes: 514 — Drug, bio-affecting and body treating compositions
510 — Cleaning compositions for solid surfaces, auxiliary compositions therefor, or processes of preparing the compositions
252 — Compositions
528 — Synthetic resins or natural rubbers -- part of the class 520 series
424 — Drug, bio-affecting and body treating compositions
428 — Stock material or miscellaneous articles
100 — Presses
Phone:(571) 272-2817
Email:angela.brown-pettigrew@uspto.gov
Location:VA 22314
Title:Supvy Pat Examnr Gen Chem
Service:13 years
Grade:GS-15

Grant Rate and Difficulty Ranking

84
3-Year Grant rate: 44% over 133 cases
Difficulty: Very Hard
Difficulty Percentile: 84th

With Examiner Brown-Pettigrew (SPE), you have a 44% chance of getting an issued patent by 3 years after the first office action. Examiner Brown-Pettigrew (SPE) is a very hard examiner and in the 84th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Brown-Pettigrew (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1761

Examiner Brown-Pettigrew (SPE)'s grant rate is lower than that of Art Unit 1761 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Brown-Pettigrew (SPE) 1.1
Art Unit 1761 1.6

Interview Benefit

Grant Rate without Interview

Examiner Brown-Pettigrew (SPE) has granted 53 of 118 cases without any applicant-requested interviews for a grant rate of 45%.

Grant Rate with Interview

Examiner Brown-Pettigrew (SPE) has granted 6 of 15 cases with at least one applicant-requested interview for a grant rate of 40%.

Interview Benefit

With Examiner Brown-Pettigrew (SPE), conducting an interview decreases your chance of getting a patent granted by 11%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18286313 Composition Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
17996148 Cleaning Composition For Oral Appliance Patented View
18041214 Purging Compound For Resin Processing Machine Abandoned View
18112776 Laundry Detergent Composition Containing Dye Fixative And Amine Oxide Patented View
17844762 Blooming Effect Using Soluble Laundry Sheets Abandoned View
18073242 Peracid Booster Patented View
18139379 Working Fluid For Heat Cycle, Composition For Heat Cycle System, And Heat Cycle System Abandoned View
17842922 Varnish For Photo Alignment Film And Liquid Crystal Display Device Abandoned View
17119138 Composition For Forming Hard Coat, Method For Producing Article Having Hard Coat, Hard Coat, Hard-Coated Article, And Silane-Modified Alicyclic Compound Abandoned View
17257667 Tetracarboxylic Dianhydride, Carbonyl Compound, Polyimide Precursor Resin, And Polyimide Abandoned View
16929638 Semiconductor Film Composition, Method For Manufacturing Semiconductor Film Composition, Method For Manufacturing Semiconductor Member, Method For Manufacturing Semiconductor Processing Material, And Semiconductor Device Patented View
17556548 Heat Transfer Compositions, Methods, And Systems Abandoned View
16962404 Organosilicon Compound And Rubber Composition Comprising The Same Abandoned View
17004558 Organic Light-Emitting Device And Flat Display Apparatus Including The Same Patented View
16716966 Heterocyclic Compound And Organic Light-Emitting Device Including The Same Abandoned View
17389560 Compositions Comprising Fluoroolefins And Uses Thereof Abandoned View
17349856 Heat Transfer Compositions, Methods And Systems Abandoned View
17342468 Azeotrope-Like Compositions Of 1,1,1,2-Tetrafluoropropene And 1,1,1,2-Tetrafluoroethane Abandoned View
17237880 Laundry Detergent Composition Abandoned View
17346367 Refrigerants With Reduced Flammability Profile Abandoned View
17255467 Refrigeration Cycle Apparatus Abandoned View
17254425 Composition Containing Refrigerant, Use Thereof, Refrigerator Having Same, And Operation Method For Said Refrigerator Abandoned View
16491878 Quasi-Azeotropic Composition Comprising 2,3,3,3-Tetrafluoropropene And Trans-1,3,3,3-Tetrafluoropropene Abandoned View
17071601 Monochlorotrifluoropropene Compounds And Compositions And Methods Using Same Abandoned View
16912166 Refrigeration Cycle Apparatus Abandoned View
16913358 Refrigeration Cycle Apparatus Abandoned View
16911816 Refrigerating Oil For Refrigerant Or Refrigerant Composition, Method For Using Refrigerating Oil, And Use Of Refrigerating Oil Abandoned View
17332261 Heat Transfer Process Abandoned View
17070235 Working Medium And Heat Cycle System Abandoned View
17320301 Compositions Comprising A Fluoroolefin Abandoned View
16529400 Treatment Of Autism Spectrum Disorder And Associated Symptoms Patented View
16248925 Combination Therapy For Treating Cancer Abandoned View
15906297 Combination Therapies Of Her2-Targeted Antibody-Drug Conjugates Abandoned View
16416518 Compounds, Compositions And Methods For Treating Oxidative Dna Damage Disorders Abandoned View
15028973 P13k Inhibitor For Treatment Of Respiratory Disease Abandoned View
15272085 Condensed [1,4] Diazepine Compounds As Autotaxin (Atx) And Lysophosphatidic Acid (Lpa) Production Inhibitors Patented View
15781110 Novel Anti-Claudin Antibodies And Methods Of Use Abandoned View
15746913 Pyrrolobenzodiazepine-Antibody Conjugates Abandoned View
16230576 Method Of Promoting Remyelination Patented View
16688094 Broad Spectrum Pharmacological Composition For Treatment Of Various Infections And Diseases And Methods Of Use Patented View
15311582 Platelet-Derived Growth Factor Receptor Mutations And Compositions And Methods Relating Thereto Patented View
15502498 Adjunctive Therapy With 25-Hydroxyvitamin D Abandoned View
16344390 New Derivatives Of Indole For The Treatment Of Endometriosis Patented View
15821984 Composition Comprising Compound Inhibiting Interactions Of Mbd2 And P66a For Anti-Metastasis And Prevention And Treatment Of Cancer Disease Patented View
15218149 Compositions And Methods For Use Of Eflornithine And Derivatives And Analogs Thereof To Treat Cancers, Including Gliomas Abandoned View
16342429 Pharmaceutical Composition For Treatment Or Remission Of Chronic Myelogenous Leukemia Abandoned View
15774129 Compositions And Methods For The Treatment Of Fatty Acid Metabolism Disorders Patented View
16352499 Formulation Of A Riluzole Solution With Beta- Cyclodextrins Abandoned View
16219730 Solid Forms Of A Compound Modulating Kinases Patented View
15949701 A3 Adenosine Receptor Agonists Patented View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...